Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Acute, Double-blind, Adaptively Randomized Treatment With Duloxetine or Escitalopram, Followed by Open-label Naturalistic Follow-up.

NCT04245436 is registered in ClinicalTrials.gov with University of Cincinnati as lead sponsor.

NCT NCT04245436
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04245436 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Acute, Double-blind, Adaptively Randomized Treatment With Duloxetine or Escitalopram, Followed by Open-label Naturalistic Follow-up.
Lead sponsor
University of Cincinnati
Phase
Phase 4
Overall status
Recruiting
Start date
January 1, 2020
Completion date
August 31, 2025
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety, depressive symptoms